Vivos Inc.

Equities

RDGL

US92858K2042

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 01:28:57 15/05/2024 am IST			5-day change	1st Jan Change
0.2008 ^USD	+1.49%		+11.87%	+177.73%

09/05	Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/03	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 10, 2022 at 11:41 pm IST

Vivos Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.013 million. Net loss was USD 0.699905 million compared to USD 0.288189 million a year ago.

Latest news about Vivos Inc.

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03	CI
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20/12	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11	CI
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	05/23/05	CI
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01/23/01	CI
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11/23/11	CI
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03/23/03	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	20/22/20	CI
Vivos Inc. Files A New Patent on the Hydrogel Component of Isopet®/Radiogel™	14/22/14	CI
Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy	16/22/16	CI
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25	CI
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/22/10	CI
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	08/22/08	CI
Vivos Inc. Auditor Raises 'Going Concern' Doubt	07/22/07	CI
Vivos Inc. Files Its Particle Patent in Several Countries	24/22/24	CI
Vivos Inc. Obtains Feedback from the FDA on Clinical Testing of RadioGel?	02/21/02	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	26/21/26	CI
Vivos Inc Signs A Memorandum of Understanding for A New Regional Clinic in Ny for Isopet Therapy	18/21/18	CI
Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™	20/21/20	CI
Vivos Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	03/21/03	CI
Vivos Inc Initiates Isopet® Therapy in Horses	24/21/24	CI
Vivos Inc Enhances Radiogel™ Manufacturing Process	24/21/24	CI

Chart Vivos Inc.

Duration

Period

More charts

Company Profile

Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Companyâs IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. The IsoPet solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. The Company is also engaged in developing a micro-injection system for small tumor therapy for treating cancerous thyroid lymph nodes.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

	1st Jan change	Capi.
VIVOS INC.	+177.73%	7.72Cr
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-0.97%	1.53TCr
IRAY TECHNOLOGY COMPANY LIMITED	-36.20%	300.5Cr
SONOSCAPE MEDICAL CORP.	-12.03%	244.36Cr
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.41%	145.81Cr
CORETAG, INC.	-.--%	112.5Cr
NANO-X IMAGING LTD.	+65.31%	59Cr
DETECTION TECHNOLOGY OYJ	+14.60%	25Cr
DRTECH CORPORATION	-2.35%	23Cr
VIEWORKS CO., LTD.	+7.96%	19Cr

Medical Imaging Systems